Sepsis-induced apoptosis of the thymocytes in mice.
Intraperitoneal injection of Gram-negative bacteria (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa) induces thymic atrophy in mice. The thymus weight, cell number, and viability began to decrease at 3 h, and reached their lowest level at 72 h. The thymocyte death was associated with DNA fragmentation of approximately 200 base pairs in ladder form. The kinetic study on histopathology revealed the process of thymocyte death and thymic atrophy. Flow-cytometric analysis showed that CD4+CD8+ thymocytes decreased predominantly. LPS caused thymocyte apoptosis, but only in LPS-responder mice, unlike Gram-negative bacteria that induced apoptosis in both LPS-responder (C3H/HeN) and LPS-nonresponder (C3H/HeJ). Gram-positive bacteria Streptococcus pneumoniae also caused apoptosis in LPS-nonresponder (C3H/HeJ) and LPS-responder mice (B6). The kinetics of serum TNF-alpha production after Gram-negative or Gram-positive bacteria injection was slightly different. E. coli induced serum TNF-alpha peak at 1 h in B6 mice, whereas S. pneumoniae induced a peak at 6 h in C3H/HeJ and at 9 h in B6 mice. Similarly, S. pneumoniae induced thymocyte apoptosis around 9 to 12 h, which was 6 to 9 h later than that observed with E. coli in B6 mice. Anti-TNF-alpha Ab completely blocked the E. coli-induced thymocyte apoptosis, but was only partially inhibitory on the S. pneumoniae-induced thymocyte apoptosis. Furthermore, thymocyte apoptosis induced by E. coli was inhibited by cycloheximide or actinomycin D. These data indicate that both Gram-negative and Gram-positive bacteria could induce thymus atrophy via apoptosis, and that TNF-alpha is a common denominator released and might be responsible for the thymocyte apoptosis.
Wang
S D
SD
Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China.
Huang
K J
KJ
Lin
Y S
YS
Lei
H Y
HY
D000818:Animals; D017209:Apoptosis; D001284:Atrophy; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D016905:Gram-Negative Bacterial Infections / Q000276:immunology* / Q000473:pathology; D016908:Gram-Positive Bacterial Infections / Q000276:immunology* / Q000473:pathology; D051379:Mice; D008809:Mice, Inbred C3H; D013601:T-Lymphocytes / Q000502:physiology*; D013950:Thymus Gland / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D014409:Tumor Necrosis Factor-alpha; D003609:Dactinomycin; D003513:Cycloheximide